Overview
Biliary atresia with splenic malformation syndrome (BASM), also known as biliary atresia splenic malformation syndrome or the syndromic form of biliary atresia, is a rare congenital condition that combines biliary atresia — a progressive obliterative cholangiopathy affecting the bile ducts — with laterality defects and splenic abnormalities. Unlike isolated (non-syndromic) biliary atresia, BASM is present from birth and is thought to arise from disrupted embryonic development of laterality during early gestation. The condition primarily affects the hepatobiliary system and the spleen, but may also involve the cardiovascular system and abdominal organ positioning. Key clinical features include neonatal jaundice (due to obstructed bile flow), acholic (pale) stools, dark urine, and hepatomegaly. Splenic malformations may include polysplenia (multiple small spleens), asplenia (absent spleen), or a double spleen. Associated anomalies can include situs inversus or situs ambiguus (abnormal positioning of abdominal and thoracic organs), preduodenal portal vein, interrupted inferior vena cava, cardiac defects (such as atrial or ventricular septal defects), and intestinal malrotation. The hepatobiliary obstruction leads to progressive liver damage, fibrosis, and eventually biliary cirrhosis if untreated. The primary surgical treatment is the Kasai portoenterostomy (hepatoportoenterostomy), which aims to restore bile flow by connecting the liver directly to the small intestine. However, outcomes of the Kasai procedure in BASM patients tend to be less favorable compared to those with isolated biliary atresia, with a higher rate of failure to clear jaundice. Liver transplantation remains the definitive treatment for patients who develop end-stage liver disease. Early diagnosis and referral to a specialized pediatric hepatobiliary center are critical for optimizing outcomes. The presence of associated cardiac and vascular anomalies may complicate surgical management and requires careful preoperative evaluation.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Biliary atresia with splenic malformation syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Biliary atresia with splenic malformation syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Biliary atresia with splenic malformation syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Biliary atresia with splenic malformation syndrome.
Community
No community posts yet. Be the first to share your experience with Biliary atresia with splenic malformation syndrome.
Start the conversation →Latest news about Biliary atresia with splenic malformation syndrome
No recent news articles for Biliary atresia with splenic malformation syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Biliary atresia with splenic malformation syndrome
What is Biliary atresia with splenic malformation syndrome?
Biliary atresia with splenic malformation syndrome (BASM), also known as biliary atresia splenic malformation syndrome or the syndromic form of biliary atresia, is a rare congenital condition that combines biliary atresia — a progressive obliterative cholangiopathy affecting the bile ducts — with laterality defects and splenic abnormalities. Unlike isolated (non-syndromic) biliary atresia, BASM is present from birth and is thought to arise from disrupted embryonic development of laterality during early gestation. The condition primarily affects the hepatobiliary system and the spleen, but may
How is Biliary atresia with splenic malformation syndrome inherited?
Biliary atresia with splenic malformation syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Biliary atresia with splenic malformation syndrome typically begin?
Typical onset of Biliary atresia with splenic malformation syndrome is neonatal. Age of onset can vary across affected individuals.